TB-500: Market Guide for Brands

tb-500 is a supporting actor and it is a good one. it almost never brings a new customer to your site by itself, but in nearly every catalog we have worked on it shows up as one of the top second purchases and one of the most common bundle components. if you understand that role, you will position it correctly. if you try to make it a hero SKU, you will overspend on traffic for a product that does not carry acquisition.

the frame, same as always in this category: tb-500 is not an approved drug and not a dietary supplement ingredient. it is sold research use only, not for human consumption. we are not covering usage, protocols, administration, or combinations, and nothing here is medical or legal advice.

the demand picture

tb-500 search volume is a fraction of bpc-157's, but the traffic quality is high — people searching this term are compound-aware, deep in the category, and typically not first-time buyers. that is a different customer than the top-of-funnel searcher, and it means your conversion rate on this traffic is often better even though the volume is smaller.

the important behavioral pattern is co-purchase. tb-500 and bpc-157 appear together in cart data constantly. we are describing purchase behavior, not making any statement about combined use — but the merchandising implication is direct: the highest-value placement for this SKU is on the bpc-157 product page, in the cart, and in the post-purchase email flow, not at the top of a cold acquisition campaign.

positioning: the attach SKU

here is how to think about the economics. your acquisition cost is paid on the first product. every additional unit added to that same order carries essentially zero incremental acquisition cost and only marginal fulfillment cost, so its contribution margin is dramatically better than the acquiring product's. a category with a strong attach product is structurally more profitable than one without, at the same traffic cost.

1. 1.merchandise it on the PDP of your highest-traffic SKU as a frequently-purchased-together module
2. 2.offer it as a cart-level add with a modest bundle incentive, not a deep discount that trains customers to wait
3. 3.include it in the post-purchase email sequence, timed to your observed reorder window
4. 4.build it into a two- or three-component bundle at a price point above your best-selling single SKU
5. 5.make it a subscription option, since research buyers who reorder tend to reorder on a schedule

the discount depth question matters more than operators think. a small bundle incentive raises AOV. a deep one teaches your customers that the real price is the discounted price and permanently resets your margin. hold the incentive shallow and make the convenience of the bundle do the work.

sourcing and COA expectations

tb-500 has more supply-side variability than the headline compounds, largely because there is less independent scrutiny of it. that cuts both ways: less public testing means fewer brands get caught, and also means you cannot rely on the market to police your supplier for you. do it yourself.

• —require a lot-specific COA tied to your purchase order, with HPLC purity and mass spec identity confirmation and the analytical method named
• —ask for net peptide content in addition to chromatographic purity — they measure different things and only one of them tells you what you actually received
• —confirm the testing laboratory exists and will verify the report independently
• —run third-party verification on your first lot from any new supplier and on a random cadence afterward
• —retain samples of every lot you sell for as long as counsel advises
• —document supply agreement terms on specification, testing, and remedy — not just price and lead time

publish lot-linked results if you can. in a category where verification is the actual differentiator, a scannable batch code that resolves to a real COA is a stronger conversion asset than any copy you could write, and it is entirely claim-free.

margins and inventory

unit economics resemble other research peptides — strong percentage gross margin, with the real answer determined by high-risk processing rates, testing spend, temperature-controlled fulfillment, and creative loss on paid media. the specific consideration for tb-500 is inventory velocity. because it sells as an attach rather than an acquisition product, its demand is a function of your hero SKU's volume, not of its own marketing. that makes it forecastable — but it also means an over-order sits on your shelf.

forecast it as a ratio to your primary SKU rather than as a standalone line. track the attach rate as a real metric, review it monthly, and size purchase orders off that ratio. brands that forecast attach SKUs independently end up with capital locked in slow inventory in a category where cash conversion is already tight because of processor holds.

marketing it compliantly

the constraint set is identical to any research-use-only product and it is strict. no claims of any kind — not about outcomes, not about research findings applied to people, not implied through testimonials or creator content. research use only, not for human consumption, everywhere. no usage guidance in support. no answering protocol questions.

• —the only things you can market on are verification, sourcing, purity documentation, packaging, shipping speed, and service
• —do not run cold paid acquisition on this SKU — the volume is not there and the risk-adjusted return is worse than putting the same dollars behind your hero product
• —owned channels do the heavy lifting: post-purchase email, replenishment sequences, and sms carry most of the attach revenue
• —brief every creator and affiliate in writing; deep-category products are exactly where affiliates freelance on claims
• —keep age gating, geo restrictions, and buyer attestation consistent across your whole catalog, not just on the headline SKU

mistakes

1. 1.running cold acquisition campaigns on a product with attach-level demand and blaming the creative when it does not work
2. 2.trusting a product-level COA instead of a lot-specific one because the supplier is established
3. 3.discounting bundles so deeply that the bundle price becomes the expected price
4. 4.forecasting inventory independently instead of as a ratio to the hero SKU, then sitting on dead stock
5. 5.letting affiliates make the claims the brand deliberately avoided
6. 6.not tracking attach rate as a managed metric, which means nobody is responsible for the number that decides your catalog's profitability

attach rate is the most profitable metric in a peptide catalog and almost nobody has an owner assigned to it.

the takeaway

give tb-500 the job it is good at. verify the supply properly, merchandise it aggressively in cart and post-purchase, forecast it against your hero SKU, keep every piece of copy claim-free, and stop spending cold traffic dollars trying to make it something it is not. done that way it is one of the highest-margin lines in the catalog.